Stay updated on TQ05105 Tablets in Refractory aGVHD Clinical Trial
Sign up to get notified when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.

Latest updates to the TQ05105 Tablets in Refractory aGVHD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision v3.5.2 was added to the record history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, replacing the previous v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedA new latest revision, v3.4.3, is added to the history and the previous revision v3.4.2 is removed.SummaryDifference0.1%

- Check77 days agoChange DetectedA new Revision: v3.4.2 was added to the record history. The government-funding/operating-status notice and the previous Revision: v3.4.1 entry were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check84 days agoChange DetectedAdded a site-wide notice about potential data delays due to a lapse in government funding and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov. Updated the record history to include Revision: v3.4.1, replacing the prior v3.4.0.SummaryDifference0.9%

- Check91 days agoChange DetectedUI changes include a 'Show glossary' toggle, color-coded highlights for additions and deletions, and updated revision text (e.g., Revision: v3.4.0).SummaryDifference1%

Stay in the know with updates to TQ05105 Tablets in Refractory aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.